BEARINGPOINT
17.11.2022 08:06:39 CET | Business Wire | Press release
E-commerce trends induced by the global pandemic took online purchasing to the next level of development. This expansion led to significant changes for all online sales and logistics processes, including an increased need to optimize customer return-order processes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221116005790/en/
In its recent client story, BearingPoint shows how it supported Kao, one of the leading global manufacturers of hair care products and cosmetics, in leveraging innovative technology to upgrade its return-order tasks.
Staying competitive in the fast-moving consumer goods (FMCG) market requires strong interconnectivity, real-time data transmission and reliable processes. In the past, managing an end-to-end process for return orders was labor-intensive and involved many employees, multiple IT devices and coordinating access to various software systems. Even when all these needs were met, the process often generated high costs and human errors in data entry along with strong dependencies.
The Kao Group aimed to leave this scenario behind and leverage innovation to gain efficiency. The company needed a better way to handle its return-order tasks, which at the time required a multi-step processing of documents and the input of data into SAP each time a request was received.
Management and technology consultancy BearingPoint worked with Kao to analyze the company’s existing processes to understand how its warehouse movements and activities – such as goods receiving, put away, storage and shipping – were translated into SAP system return-order data. A technical “to be” process was designed, which covered future workflow steps in detail, transaction loads, business rules, error handling, risks, dependencies and unknown exceptions.
Happy users and even more satisfied customers
“The RPA solution we used for Kao has made the company much more competitive. It not only automated the return order processes but freed up employees to do more value-added work. RPA solutions can benefit businesses in all industries, and it’s incredible how much they free up the workforce,” said Andreas Fitz, Partner at BearingPoint.
By leveraging UiPath’s RPA, BearingPoint developed a solution that formatted return-order email information automatically to create the required documents in SAP. The solution uses a bot first to extract relevant information – like original sales order, customer number, material code, and unrestricted and blocked quantities. It then immediately performs return orders, inbound delivery, and goods receipt transactions in SAP. The process is completed by sending out email notifications to Kao’s Customer Service department.
“With BearingPoint at our side, we were able to streamline and reduce a lot of manual work in a cumbersome internal process! Setting the bot solution live led to happy users and even more satisfied customers!” said Suyin Boehnke, SAP Senior Business Relationship Manager SCM EMEA, The Kao Group.
Kao can now process all its return-order tasks faster and more consistently, regardless of demand or data volume peaks. By using automation, the required documentation is processed 24/7 without significant interruptions or delays. The RPA solution provides transparent and accurate inventory data for further process improvements, such as stock and demand planning. Kao’s products that are eligible for resale are inserted into the marketplace workflow rapidly, thus reaching customers faster.
The company can now rely on an efficient process involving no additional interfaces, system access or need for human interaction, resulting in substantial cost optimization. The bot removes any risk of human error while freeing up time for Kao’s staff to work on other business-related, value-adding activities.
You can read the full client success story here: https://www.bearingpoint.com/en/insights-events/client-stories/kao-return-order-process-automation/
About Kao
Kao creates high-value-added products and services that provide care and enrichment for the lives of all people and the planet. Through its portfolio of over 20 leading brands – such as Oribe, Attack, Bioré, Goldwell, Jergens, John Frieda, Kanebo, Laurier, Merries and Molton Brown – Kao is part of the everyday lives of people in Asia, Oceania, North America, and Europe. Combined with its chemical business, which contributes to a wide range of industries, Kao generates about 1,420 billion yen in annual sales. Kao employs about 33,500 people worldwide and has 135 years of history in innovation.
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 13,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005790/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
